Prospectus

Highland Transcend Partners I Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing January 25, 2021

Friday, January 22, 2021 - 10:38pm

Shares of Class A common stock and warrants that are separated will trade on the New York Stock Exchange under the symbols HTAP and HTAP WS, respectively.

Key Points: 
  • Shares of Class A common stock and warrants that are separated will trade on the New York Stock Exchange under the symbols HTAP and HTAP WS, respectively.
  • Those units not separated will continue to trade on the New York Stock Exchange under the symbol HTAP.U.
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Copies of the prospectus may be obtained, for free by visiting EDGAR on the SECs website at www.sec.gov .

China Natural Resources, Inc. Announces The Closing Of $7.3 Million Registered Direct Offering

Friday, January 22, 2021 - 9:53pm

The Company issued a total of 3,960,000 common shares to the institutional investors participating in the offering.

Key Points: 
  • The Company issued a total of 3,960,000 common shares to the institutional investors participating in the offering.
  • The net proceeds from this offering will be used for general corporate purposes.
  • The prospectus supplement and accompanying prospectus relating to the registered direct offering was filed with the SEC and is available on the SEC's website located at http://www.sec.gov .
  • Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Friday, January 22, 2021 - 9:00pm

The total gross proceeds of the offering were $50.6 million, before deducting underwriting discounts and commissions and offering expenses payable by Fulcrum.

Key Points: 
  • The total gross proceeds of the offering were $50.6 million, before deducting underwriting discounts and commissions and offering expenses payable by Fulcrum.
  • All of the shares in the offering were sold by Fulcrum.
  • SVB Leerink, Piper Sandler & Co. and Credit Suisse acted as joint book-running managers for the offering.
  • This offering was made only by means of a prospectus and prospectus supplement that form a part of the registration statement.

COMSovereign Holding Corp. Announces Nasdaq Listing and Pricing of $16.0 Million Public Offering

Friday, January 22, 2021 - 1:20am

In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 578,312 units at the public offering price less the underwriting discounts and commissions.

Key Points: 
  • In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 578,312 units at the public offering price less the underwriting discounts and commissions.
  • The offering is expected to close on January 26, 2021, subject to satisfaction of customary closing conditions.
  • Before investing in this offering, interested parties should read in their entirety the prospectus, which provides more information about the Company and such offering.
  • COMSovereign Holding Corp. (Nasdaq: COMS) has assembled a portfolio of communications technology companies that enhance connectivity across the entire data transmission spectrum.

Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio

Wednesday, January 20, 2021 - 11:28pm

333-250036) (as amended, the Registration Statement), relating to the previously announced business combination (the Business Combination) with Nuvation Bio Inc. (Nuvation Bio), has been declared effective by the U.S. Securities and Exchange Commission (SEC) and that it has commenced mailing the definitive proxy statement/prospectus relating to the Special Meeting (the Special Meeting) of the Companys stockholders to be held on February 9, 2021 in connection with the Business Combination.

Key Points: 
  • 333-250036) (as amended, the Registration Statement), relating to the previously announced business combination (the Business Combination) with Nuvation Bio Inc. (Nuvation Bio), has been declared effective by the U.S. Securities and Exchange Commission (SEC) and that it has commenced mailing the definitive proxy statement/prospectus relating to the Special Meeting (the Special Meeting) of the Companys stockholders to be held on February 9, 2021 in connection with the Business Combination.
  • These forward-looking statements include, but are not limited to, statements regarding timing of the special meeting for the proposed Business Combination.
  • The Company and Nuvation Bio anticipate that subsequent events and developments will cause the Companys and Nuvation Bios assessments to change.
  • Additional Information and Where to Find It:
    This press release relates to a proposed transaction between Nuvation Bio and the Company.

OncoSec Medical Announces Proposed Public Offering of Common Stock

Wednesday, January 20, 2021 - 9:35pm

All of the shares to be sold in the offering will be offered by OncoSec.

Key Points: 
  • All of the shares to be sold in the offering will be offered by OncoSec.
  • OncoSec will file a preliminary prospectus supplement and accompanying base prospectus to its effective shelf registration statement on Form S-3 (File No.
  • 333-233447) with the U.S. Securities and Exchange Commission ("SEC") for the proposed public offering of its common stock.
  • The offering of these securities is being made under an effective shelf registration statement on file with the SEC.

Life & Banc Split Corp. Announces Successful Overnight Offering

Wednesday, January 20, 2021 - 9:37pm

For further information, please contact your investment advisor, call Bromptons investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email info@bromptongroup.com or visit our website at www.bromptongroup.com .

Key Points: 
  • For further information, please contact your investment advisor, call Bromptons investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email info@bromptongroup.com or visit our website at www.bromptongroup.com .
  • Copies of the short form base shelf prospectus may be obtained from a member of the syndicate.
  • An investment fund must prepare disclosure documents that contain key information about the fund.
  • Life & Banc Split Corp.

Silvergate Launches Follow-on Public Offering of Class A Common Stock

Wednesday, January 20, 2021 - 9:22pm

Silvergate Capital Corporation (Silvergate or the Company) announced today the launch of an underwritten public offering of $200 million of shares of Class A common stock pursuant to an effective Registration Statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC).

Key Points: 
  • Silvergate Capital Corporation (Silvergate or the Company) announced today the launch of an underwritten public offering of $200 million of shares of Class A common stock pursuant to an effective Registration Statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC).
  • The Company also expects to grant the underwriters a 30-day option to purchase up to an additional $30 million of shares of Class A common stock.
  • Goldman Sachs & Co. LLC, Keefe, Bruyette & Woods, A Stifel Company, and Canaccord Genuity will act as joint lead book-running managers.
  • Before you invest, you should read the prospectus in the Registration Statement, the related preliminary prospectus supplement and the other documents Silvergate has filed with the SEC for more complete information about Silvergate and this offering.

Docebo Announces Secondary Public Offering in the United States and Canada

Wednesday, January 20, 2021 - 9:02pm

Docebo Inc. (Docebo) (TSX: DCBO; Nasdaq: DCBO) today announced the launch of a marketed secondary public offering of Docebos common shares in the United States and Canada.

Key Points: 
  • Docebo Inc. (Docebo) (TSX: DCBO; Nasdaq: DCBO) today announced the launch of a marketed secondary public offering of Docebos common shares in the United States and Canada.
  • Docebo will not receive any of the proceeds from the sale of common shares by the Selling Shareholders.
  • In connection with the offering, Docebo filed a preliminary prospectus supplement to its base shelf prospectus with the securities regulatory authorities in each of the provinces and territories of Canada.
  • The public offering will be made in Canada only by means of the base shelf prospectus and preliminary prospectus supplement and in the United States only by means of the registration statement, including the base shelf prospectus and preliminary prospectus supplement.

TUI AG: Notification and public disclosure of transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

Wednesday, January 20, 2021 - 4:04pm

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • PLEASE READ THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.
  • The attached notification, made in accordance with the requirements of MAR, give further detail.
  • All capitalised terms used but not otherwise defined in this announcement including the important notices below have the meaning set out in the Prospectus.